Study directory

PTSD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
2805studies shown
Showing 901-912 of 2,805
Drug study icon
Active Not RecruitingNCT06407635

Psilocybin for PTSD

This study is active but not recruiting in the United States. It is testing psilocybin for PTSD.

In Baltimore
Why is this study shown?

This study is directly about PTSD.

PTSDDrugA study involving a medication or substance.From 21 Years to 75 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
PTSD
Drug study icon
TerminatedNCT02216097

Effects Of PF-04457845 On BOLD fMRI In Subjects With PTSD

This study was terminated in the United States. It is testing Effects Of PF-04457845 On BOLD fMRI for PTSD.

In New York
Why is this study shown?

This study is directly about PTSD.

PTSDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Pfizer
Condition
PTSD
Behavioral study icon
CompletedNCT03114891

Accelerated TMS to a Novel Brain Target in MDD and PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Philadelphia
Why is this study shown?

This study is directly about PTSD.

PTSD, DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
PTSD, Depression
Other study type icon
CompletedNCT01614444

Acupressure and Stress Resilience

This summary needs review. Please check the official study record and contact the research team for details.

In Denver
Why is this study shown?

This study is directly about PTSD.

PTSDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
VA Eastern Colorado Health Care System
Condition
PTSD
Behavioral study icon
WithdrawnNCT05606172

Adaptation of the PCIP for Children Aged 6 to 11

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
Why is this study shown?

This study is directly about PTSD.

PTSDBehavioralFrom 6 Years to 11 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
PTSD
Behavioral study icon
WithdrawnNCT05899322

Adaptation of the PCIP for Spanish Speaking Adolescents and Families

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
Why is this study shown?

This study is directly about PTSD.

PTSDBehavioralFrom 12 Years to 22 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
PTSD
Device study icon
CompletedNCT00920036

Adjunctive Biofeedback Intervention for Operation Iraqi Freedom/Operation Enduring Freedom (OIF-OEF) PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about PTSD.

PTSDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
Sponsor
Central Arkansas Veterans Healthcare System
Condition
PTSD
Behavioral study icon
WithdrawnNCT05088915

Adolescent PCIP Feasibility study

This study was withdrawn in the United States. It focuses on PTSD.

In Los Angeles
Why is this study shown?

This study is directly about PTSD.

PTSDBehavioralFrom 12 Years to 22 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
PTSD
Behavioral study icon
CompletedNCT06993012

An Integrative, Digital Health Approach to Veteran-Centered PTSD Care

This summary needs review. Please check the official study record and contact the research team for details.

In College Station
Why is this study shown?

This study is directly about PTSD.

PTSD, Depression, ...BehavioralOver 18 Years
Countries
United States
Sponsor
Texas A&M University
Condition
PTSD, Depression, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.